Loading page…
Cosmo Pharmaceuticals NV 2024 Sustainability Report
Company: Cosmo Pharmaceuticals NV
Sector: Manufacturing
Country: Ireland
Year: 2024
Type: Sustainability Report
Pages: 69
The report presents Cosmo's 2024 sustainability performance through a double materiality assessment, including Scope 1 and 2 emissions of 5,714 tonnes CO2eq and targets for a 15% reduction by 2025, 50% by 2030 and net zero by 2035. It reports 322 employees, with women representing 37% of the workforce. The report also details environmental data on electricity, natural gas, water and waste and describes governance through Board and ESG Committee oversight.
Indicators available in this report: